Abstract
The Enterobacteriaceae is a large family of Gram-negative, facultative anaerobic, non-spore forming rod-shaped bacteria that includes harmless and pathogenic organisms. The emergence and development of drug resistance in Enterobacteriaceae is complicating the treatment of serious infections. The aim of this study is to predict and characterize putative drug targets in Enterobacteriaceae family employing a homology-based computational method. The final putative drug targets were qualitatively characterized via cellular function prediction, subcellular localization prediction, broad-spectrum, and druggability analyses. Of 6,327 analyzed proteins, 35 proteins were selected as final putative drug targets in Enterobacteriaceae family. These putative drug targets were involved in different vital pathways like metabolism, biosynthesis of macromolecule, and cell division. Predicted drug targets were also localized in the cytoplasm and cytoplasmic membrane of the pathogen that acts as antimicrobial or vaccine targets. Of 35 drug targets, 5 targets were druggable and 30 targets were not druggable and were predicted as novel drug targets, which should be further evaluated to develop new antimicrobial. Thirteen drug targets were considered...Continue Reading
References
Sep 28, 2005·Biochimica Et Biophysica Acta·Jeanne A GeyerNorman C Waters
Oct 11, 2005·Computational Biology and Chemistry·Sharmila AnishettyGautam Pennathur
Jan 24, 2006·Journal of Chemical Information and Modeling·Om Prakash, Indira Ghosh
Jun 1, 2006·The American Journal of Medicine·David L Paterson
Jun 9, 2007·BMC Systems Biology·Neema Jamshidi, Bernhard Ø Palsson
May 20, 2008·Bioorganic & Medicinal Chemistry Letters·Aldo Segura-Cabrera, Mario A Rodríguez-Pérez
May 29, 2008·BMC Medical Genomics·Anat ZviAvigdor Shafferman
Dec 23, 2008·BMC Systems Biology·Karthik RamanNagasuma Chandra
Jan 13, 2009·Drug Discovery Today·Yongliang YangAmin I Kassis
Apr 21, 2009·Journal of Bacteriology·Deok-Sun LeeVinayak Kapatral
May 8, 2009·The Journal of General Virology·Vivek DarapaneniAndreas Kukol
Apr 22, 2010·BMC Bioinformatics·Tala M Bakheet, Andrew J Doig
Sep 3, 2010·BMC Systems Biology·Carola HuthmacherHermann-Georg Holzhütter
Jan 29, 2011·BMC Genomics·Ana Karina R AbadioMaria Sueli S Felipe
Jan 1, 2010·Journal of Chemical Biology·U AmineniH Marisetty
Aug 19, 2011·Journal of Molecular Modeling·Munmun SarkarChitra Dutta
Jul 4, 2012·Annual Review of Microbiology·Emily J Capra, Michael T Laub
Aug 23, 2012·PloS One·Azeem Mehmood ButtYigang Tong
Mar 26, 2013·PloS One·Buvaneswari Shanmugham, Archana Pan
May 1, 2013·Nature Reviews. Drug Discovery·Kim Lewis
Nov 10, 2013·Nucleic Acids Research·Vivian LawDavid S Wishart
Jan 31, 2014·Pathogens and Disease·Yurong WenBart Devreese
Feb 27, 2014·Computational Biology and Chemistry·Yao LuLong Jason Lu
Apr 10, 2014·Infectious Disorders Drug Targets·Nageswara R R NeelapuAmita C M Pasupuleti
Jan 29, 2016·Drug Discovery Today·Ali Akbar JamaliEsmaeil Ebrahimie
Citations
Aug 3, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Seyyed Mohsen SohrabiMorteza Hadizadeh
Jul 19, 2018·Scientific Reports·Pablo Ivan Pereira RamosMarisa F Nicolás
Nov 25, 2020·Phytochemistry·Sara EmamifarMaasume Shahmohammadi
Nov 21, 2020·Current Genomics·Rahul Semwal, Pritish Kumar Varadwaj
Jun 3, 2021·Antibiotics·Frida Svanberg FrisingerLuca Guardabassi
Jul 20, 2021·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Zarrin BasharatNoor Rahman
Aug 5, 2021·Malaria Journal·Fawad AliAsifullah Khan